Cargando…
Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension
Systemic arterial hypertension (SAH), a clinical syndrome characterized by persistent elevation of arterial pressure, is often associated with abnormalities such as microvascular rarefaction, defective angiogenesis, and endothelial dysfunction. Mesenchymal stem cells (MSCs), which normally induce an...
Autores principales: | de Oliveira, Lucas Felipe, Almeida, Thalles Ramos, Ribeiro Machado, Marcus Paulo, Cuba, Marilia Beatriz, Alves, Angélica Cristina, da Silva, Marcos Vinícius, Rodrigues Júnior, Virmondes, Dias da Silva, Valdo José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537741/ https://www.ncbi.nlm.nih.gov/pubmed/26300922 http://dx.doi.org/10.1155/2015/685383 |
Ejemplares similares
-
Multipotent stem cells of the heart—do they have therapeutic promise?
por: Leite, Camila F., et al.
Publicado: (2015) -
Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
por: Carvalho, Juliana L, et al.
Publicado: (2013) -
CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum
por: Lopes, Carolina S., et al.
Publicado: (2016) -
Opposite Effects of Bone Marrow-Derived Cells Transplantation in MPTP-rat Model of Parkinson's Disease: A Comparison Study of Mononuclear and Mesenchymal Stem Cells
por: Capitelli, Caroline Santos, et al.
Publicado: (2014) -
Immunological characteristics of mesenchymal stem cells
por: Machado, Cíntia de Vasconcellos, et al.
Publicado: (2013)